Skip to main content

PGA Tour suspends Hensby for anti-doping violation

Getty Images

Mark Hensby has been suspended for one year by the PGA Tour for violating the Tour’s anti-doping policy by failing to provide a sample after notification.

The Tour made the announcement Monday, reporting that Hensby will be eligible to return on Oct. 26, 2018.

The statement reads:

The PGA Tour announced today that Mark Hensby has violated the Tour Anti-Doping Policy for failing to provide a drug testing sample after notification and has been suspended for a period of one year. He will be eligible to return on Oct. 26, 2018.

Hensby, 46, won the John Deere Classic in 2004. He played the Web.com Tour this past year, playing just 14 events. He finished 142nd on the money list. He once ranked among the top 30 in the Official World Golf Ranking but ranks No. 1,623 today.

The Sunshine Tour recently suspended player Etienne Bond for one year for failing a drug test. Players previously suspended by the PGA Tour for violating the anti-doping policy include Scott Stallings and Doug Barron.

The PGA Tour implemented revisions to its anti-doping program with the start of the 2017-18 season. The revisions include blood testing and the supplementation of the Tour’s prohibited list to include all of the substances and methods on the World Anti-Doping Agency prohibited list. As part of this season’s revisions, the Tour announced it would also begin reporting suspensions due to recreational drug use.

The Tour said it would not issue further comment on Hensby's suspension.